Medical Devices & Consumables

Global Self-administered Parenteral Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Self-administered Parenteral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-administered Parenteral.
The Self-administered Parenteral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Self-administered Parenteral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-administered Parenteral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Becton, Dickinson and Company
scPharmaceuticals
Harro Hofliger
Owen Mumford
Haselmeier
Stevanato Group
Ypsomed AG
Solteam Group
AstraZeneca
Enable lnjections
CCBio
Phillips-Medisize Corporation
Sorrel Medical
Krontec Healthcare
Subcuject Aps
Ascendia Pharmaceuticals
West Pharmaceutical Services, Inc.
Segment by Type
Pre-filled Syringes
Autoinjectors
Pen Injectors
Others
Segment by Application
Pharmacy
Online Sales
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Self-administered Parenteral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Self-administered Parenteral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Self-administered Parenteral Market Overview
1.1 Product Definition
1.2 Self-administered Parenteral by Type
1.2.1 Global Self-administered Parenteral Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pre-filled Syringes
1.2.3 Autoinjectors
1.2.4 Pen Injectors
1.2.5 Others
1.3 Self-administered Parenteral by Application
1.3.1 Global Self-administered Parenteral Market Value by Application (2024 VS 2031)
1.3.2 Pharmacy
1.3.3 Online Sales
1.3.4 Other
1.4 Global Self-administered Parenteral Market Size Estimates and Forecasts
1.4.1 Global Self-administered Parenteral Revenue 2020-2031
1.4.2 Global Self-administered Parenteral Sales 2020-2031
1.4.3 Global Self-administered Parenteral Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Self-administered Parenteral Market Competition by Manufacturers
2.1 Global Self-administered Parenteral Sales Market Share by Manufacturers (2020-2025)
2.2 Global Self-administered Parenteral Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Self-administered Parenteral Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Self-administered Parenteral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Self-administered Parenteral, Product Type & Application
2.7 Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
2.8 Global Self-administered Parenteral Market Competitive Situation and Trends
2.8.1 Global Self-administered Parenteral Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Self-administered Parenteral Players Market Share by Revenue
2.8.3 Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Self-administered Parenteral Market Scenario by Region
3.1 Global Self-administered Parenteral Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Self-administered Parenteral Sales by Region: 2020-2031
3.2.1 Global Self-administered Parenteral Sales by Region: 2020-2025
3.2.2 Global Self-administered Parenteral Sales by Region: 2026-2031
3.3 Global Self-administered Parenteral Revenue by Region: 2020-2031
3.3.1 Global Self-administered Parenteral Revenue by Region: 2020-2025
3.3.2 Global Self-administered Parenteral Revenue by Region: 2026-2031
3.4 North America Self-administered Parenteral Market Facts & Figures by Country
3.4.1 North America Self-administered Parenteral Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Self-administered Parenteral Sales by Country (2020-2031)
3.4.3 North America Self-administered Parenteral Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Self-administered Parenteral Market Facts & Figures by Country
3.5.1 Europe Self-administered Parenteral Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Self-administered Parenteral Sales by Country (2020-2031)
3.5.3 Europe Self-administered Parenteral Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Self-administered Parenteral Market Facts & Figures by Region
3.6.1 Asia Pacific Self-administered Parenteral Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Self-administered Parenteral Sales by Region (2020-2031)
3.6.3 Asia Pacific Self-administered Parenteral Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Self-administered Parenteral Market Facts & Figures by Country
3.7.1 Latin America Self-administered Parenteral Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Self-administered Parenteral Sales by Country (2020-2031)
3.7.3 Latin America Self-administered Parenteral Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Self-administered Parenteral Market Facts & Figures by Country
3.8.1 Middle East and Africa Self-administered Parenteral Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Self-administered Parenteral Sales by Country (2020-2031)
3.8.3 Middle East and Africa Self-administered Parenteral Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Self-administered Parenteral Sales by Type (2020-2031)
4.1.1 Global Self-administered Parenteral Sales by Type (2020-2025)
4.1.2 Global Self-administered Parenteral Sales by Type (2026-2031)
4.1.3 Global Self-administered Parenteral Sales Market Share by Type (2020-2031)
4.2 Global Self-administered Parenteral Revenue by Type (2020-2031)
4.2.1 Global Self-administered Parenteral Revenue by Type (2020-2025)
4.2.2 Global Self-administered Parenteral Revenue by Type (2026-2031)
4.2.3 Global Self-administered Parenteral Revenue Market Share by Type (2020-2031)
4.3 Global Self-administered Parenteral Price by Type (2020-2031)
5 Segment by Application
5.1 Global Self-administered Parenteral Sales by Application (2020-2031)
5.1.1 Global Self-administered Parenteral Sales by Application (2020-2025)
5.1.2 Global Self-administered Parenteral Sales by Application (2026-2031)
5.1.3 Global Self-administered Parenteral Sales Market Share by Application (2020-2031)
5.2 Global Self-administered Parenteral Revenue by Application (2020-2031)
5.2.1 Global Self-administered Parenteral Revenue by Application (2020-2025)
5.2.2 Global Self-administered Parenteral Revenue by Application (2026-2031)
5.2.3 Global Self-administered Parenteral Revenue Market Share by Application (2020-2031)
5.3 Global Self-administered Parenteral Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Becton, Dickinson and Company
6.1.1 Becton, Dickinson and Company Company Information
6.1.2 Becton, Dickinson and Company Description and Business Overview
6.1.3 Becton, Dickinson and Company Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Becton, Dickinson and Company Self-administered Parenteral Product Portfolio
6.1.5 Becton, Dickinson and Company Recent Developments/Updates
6.2 scPharmaceuticals
6.2.1 scPharmaceuticals Company Information
6.2.2 scPharmaceuticals Description and Business Overview
6.2.3 scPharmaceuticals Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.2.4 scPharmaceuticals Self-administered Parenteral Product Portfolio
6.2.5 scPharmaceuticals Recent Developments/Updates
6.3 Harro Hofliger
6.3.1 Harro Hofliger Company Information
6.3.2 Harro Hofliger Description and Business Overview
6.3.3 Harro Hofliger Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Harro Hofliger Self-administered Parenteral Product Portfolio
6.3.5 Harro Hofliger Recent Developments/Updates
6.4 Owen Mumford
6.4.1 Owen Mumford Company Information
6.4.2 Owen Mumford Description and Business Overview
6.4.3 Owen Mumford Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Owen Mumford Self-administered Parenteral Product Portfolio
6.4.5 Owen Mumford Recent Developments/Updates
6.5 Haselmeier
6.5.1 Haselmeier Company Information
6.5.2 Haselmeier Description and Business Overview
6.5.3 Haselmeier Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Haselmeier Self-administered Parenteral Product Portfolio
6.5.5 Haselmeier Recent Developments/Updates
6.6 Stevanato Group
6.6.1 Stevanato Group Company Information
6.6.2 Stevanato Group Description and Business Overview
6.6.3 Stevanato Group Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Stevanato Group Self-administered Parenteral Product Portfolio
6.6.5 Stevanato Group Recent Developments/Updates
6.7 Ypsomed AG
6.7.1 Ypsomed AG Company Information
6.7.2 Ypsomed AG Description and Business Overview
6.7.3 Ypsomed AG Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed AG Self-administered Parenteral Product Portfolio
6.7.5 Ypsomed AG Recent Developments/Updates
6.8 Solteam Group
6.8.1 Solteam Group Company Information
6.8.2 Solteam Group Description and Business Overview
6.8.3 Solteam Group Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Solteam Group Self-administered Parenteral Product Portfolio
6.8.5 Solteam Group Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Self-administered Parenteral Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Enable lnjections
6.10.1 Enable lnjections Company Information
6.10.2 Enable lnjections Description and Business Overview
6.10.3 Enable lnjections Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Enable lnjections Self-administered Parenteral Product Portfolio
6.10.5 Enable lnjections Recent Developments/Updates
6.11 CCBio
6.11.1 CCBio Company Information
6.11.2 CCBio Description and Business Overview
6.11.3 CCBio Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CCBio Self-administered Parenteral Product Portfolio
6.11.5 CCBio Recent Developments/Updates
6.12 Phillips-Medisize Corporation
6.12.1 Phillips-Medisize Corporation Company Information
6.12.2 Phillips-Medisize Corporation Description and Business Overview
6.12.3 Phillips-Medisize Corporation Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Phillips-Medisize Corporation Self-administered Parenteral Product Portfolio
6.12.5 Phillips-Medisize Corporation Recent Developments/Updates
6.13 Sorrel Medical
6.13.1 Sorrel Medical Company Information
6.13.2 Sorrel Medical Description and Business Overview
6.13.3 Sorrel Medical Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sorrel Medical Self-administered Parenteral Product Portfolio
6.13.5 Sorrel Medical Recent Developments/Updates
6.14 Krontec Healthcare
6.14.1 Krontec Healthcare Company Information
6.14.2 Krontec Healthcare Description and Business Overview
6.14.3 Krontec Healthcare Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Krontec Healthcare Self-administered Parenteral Product Portfolio
6.14.5 Krontec Healthcare Recent Developments/Updates
6.15 Subcuject Aps
6.15.1 Subcuject Aps Company Information
6.15.2 Subcuject Aps Description and Business Overview
6.15.3 Subcuject Aps Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Subcuject Aps Self-administered Parenteral Product Portfolio
6.15.5 Subcuject Aps Recent Developments/Updates
6.16 Ascendia Pharmaceuticals
6.16.1 Ascendia Pharmaceuticals Company Information
6.16.2 Ascendia Pharmaceuticals Description and Business Overview
6.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Product Portfolio
6.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
6.17 West Pharmaceutical Services, Inc.
6.17.1 West Pharmaceutical Services, Inc. Company Information
6.17.2 West Pharmaceutical Services, Inc. Description and Business Overview
6.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales, Revenue and Gross Margin (2020-2025)
6.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Product Portfolio
6.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Self-administered Parenteral Industry Chain Analysis
7.2 Self-administered Parenteral Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Self-administered Parenteral Production Mode & Process Analysis
7.4 Self-administered Parenteral Sales and Marketing
7.4.1 Self-administered Parenteral Sales Channels
7.4.2 Self-administered Parenteral Distributors
7.5 Self-administered Parenteral Customer Analysis
8 Self-administered Parenteral Market Dynamics
8.1 Self-administered Parenteral Industry Trends
8.2 Self-administered Parenteral Market Drivers
8.3 Self-administered Parenteral Market Challenges
8.4 Self-administered Parenteral Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Self-administered Parenteral Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Self-administered Parenteral Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Self-administered Parenteral Market Competitive Situation by Manufacturers in 2024
Table 4. Global Self-administered Parenteral Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Self-administered Parenteral Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Self-administered Parenteral Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Self-administered Parenteral Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Self-administered Parenteral Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Self-administered Parenteral, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Self-administered Parenteral, Product Type & Application
Table 12. Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Self-administered Parenteral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-administered Parenteral as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Self-administered Parenteral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Self-administered Parenteral Sales by Region (2020-2025) & (K Units)
Table 18. Global Self-administered Parenteral Sales Market Share by Region (2020-2025)
Table 19. Global Self-administered Parenteral Sales by Region (2026-2031) & (K Units)
Table 20. Global Self-administered Parenteral Sales Market Share by Region (2026-2031)
Table 21. Global Self-administered Parenteral Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Self-administered Parenteral Revenue Market Share by Region (2020-2025)
Table 23. Global Self-administered Parenteral Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Self-administered Parenteral Revenue Market Share by Region (2026-2031)
Table 25. North America Self-administered Parenteral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Self-administered Parenteral Sales by Country (2020-2025) & (K Units)
Table 27. North America Self-administered Parenteral Sales by Country (2026-2031) & (K Units)
Table 28. North America Self-administered Parenteral Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Self-administered Parenteral Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Self-administered Parenteral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Self-administered Parenteral Sales by Country (2020-2025) & (K Units)
Table 32. Europe Self-administered Parenteral Sales by Country (2026-2031) & (K Units)
Table 33. Europe Self-administered Parenteral Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Self-administered Parenteral Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Self-administered Parenteral Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Self-administered Parenteral Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Self-administered Parenteral Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Self-administered Parenteral Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Self-administered Parenteral Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Self-administered Parenteral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Self-administered Parenteral Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Self-administered Parenteral Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Self-administered Parenteral Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Self-administered Parenteral Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Self-administered Parenteral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Self-administered Parenteral Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Self-administered Parenteral Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Self-administered Parenteral Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Self-administered Parenteral Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Self-administered Parenteral Sales (K Units) by Type (2020-2025)
Table 51. Global Self-administered Parenteral Sales (K Units) by Type (2026-2031)
Table 52. Global Self-administered Parenteral Sales Market Share by Type (2020-2025)
Table 53. Global Self-administered Parenteral Sales Market Share by Type (2026-2031)
Table 54. Global Self-administered Parenteral Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Self-administered Parenteral Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Self-administered Parenteral Revenue Market Share by Type (2020-2025)
Table 57. Global Self-administered Parenteral Revenue Market Share by Type (2026-2031)
Table 58. Global Self-administered Parenteral Price (US$/Unit) by Type (2020-2025)
Table 59. Global Self-administered Parenteral Price (US$/Unit) by Type (2026-2031)
Table 60. Global Self-administered Parenteral Sales (K Units) by Application (2020-2025)
Table 61. Global Self-administered Parenteral Sales (K Units) by Application (2026-2031)
Table 62. Global Self-administered Parenteral Sales Market Share by Application (2020-2025)
Table 63. Global Self-administered Parenteral Sales Market Share by Application (2026-2031)
Table 64. Global Self-administered Parenteral Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Self-administered Parenteral Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Self-administered Parenteral Revenue Market Share by Application (2020-2025)
Table 67. Global Self-administered Parenteral Revenue Market Share by Application (2026-2031)
Table 68. Global Self-administered Parenteral Price (US$/Unit) by Application (2020-2025)
Table 69. Global Self-administered Parenteral Price (US$/Unit) by Application (2026-2031)
Table 70. Becton, Dickinson and Company Company Information
Table 71. Becton, Dickinson and Company Description and Business Overview
Table 72. Becton, Dickinson and Company Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Becton, Dickinson and Company Self-administered Parenteral Product
Table 74. Becton, Dickinson and Company Recent Developments/Updates
Table 75. scPharmaceuticals Company Information
Table 76. scPharmaceuticals Description and Business Overview
Table 77. scPharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. scPharmaceuticals Self-administered Parenteral Product
Table 79. scPharmaceuticals Recent Developments/Updates
Table 80. Harro Hofliger Company Information
Table 81. Harro Hofliger Description and Business Overview
Table 82. Harro Hofliger Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Harro Hofliger Self-administered Parenteral Product
Table 84. Harro Hofliger Recent Developments/Updates
Table 85. Owen Mumford Company Information
Table 86. Owen Mumford Description and Business Overview
Table 87. Owen Mumford Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Owen Mumford Self-administered Parenteral Product
Table 89. Owen Mumford Recent Developments/Updates
Table 90. Haselmeier Company Information
Table 91. Haselmeier Description and Business Overview
Table 92. Haselmeier Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Haselmeier Self-administered Parenteral Product
Table 94. Haselmeier Recent Developments/Updates
Table 95. Stevanato Group Company Information
Table 96. Stevanato Group Description and Business Overview
Table 97. Stevanato Group Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Stevanato Group Self-administered Parenteral Product
Table 99. Stevanato Group Recent Developments/Updates
Table 100. Ypsomed AG Company Information
Table 101. Ypsomed AG Description and Business Overview
Table 102. Ypsomed AG Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ypsomed AG Self-administered Parenteral Product
Table 104. Ypsomed AG Recent Developments/Updates
Table 105. Solteam Group Company Information
Table 106. Solteam Group Description and Business Overview
Table 107. Solteam Group Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Solteam Group Self-administered Parenteral Product
Table 109. Solteam Group Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. AstraZeneca Self-administered Parenteral Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Enable lnjections Company Information
Table 116. Enable lnjections Description and Business Overview
Table 117. Enable lnjections Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Enable lnjections Self-administered Parenteral Product
Table 119. Enable lnjections Recent Developments/Updates
Table 120. CCBio Company Information
Table 121. CCBio Description and Business Overview
Table 122. CCBio Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. CCBio Self-administered Parenteral Product
Table 124. CCBio Recent Developments/Updates
Table 125. Phillips-Medisize Corporation Company Information
Table 126. Phillips-Medisize Corporation Description and Business Overview
Table 127. Phillips-Medisize Corporation Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Phillips-Medisize Corporation Self-administered Parenteral Product
Table 129. Phillips-Medisize Corporation Recent Developments/Updates
Table 130. Sorrel Medical Company Information
Table 131. Sorrel Medical Description and Business Overview
Table 132. Sorrel Medical Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sorrel Medical Self-administered Parenteral Product
Table 134. Sorrel Medical Recent Developments/Updates
Table 135. Krontec Healthcare Company Information
Table 136. Krontec Healthcare Description and Business Overview
Table 137. Krontec Healthcare Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Krontec Healthcare Self-administered Parenteral Product
Table 139. Krontec Healthcare Recent Developments/Updates
Table 140. Subcuject Aps Company Information
Table 141. Subcuject Aps Description and Business Overview
Table 142. Subcuject Aps Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Subcuject Aps Self-administered Parenteral Product
Table 144. Subcuject Aps Recent Developments/Updates
Table 145. Ascendia Pharmaceuticals Company Information
Table 146. Ascendia Pharmaceuticals Description and Business Overview
Table 147. Ascendia Pharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Ascendia Pharmaceuticals Self-administered Parenteral Product
Table 149. Ascendia Pharmaceuticals Recent Developments/Updates
Table 150. West Pharmaceutical Services, Inc. Company Information
Table 151. West Pharmaceutical Services, Inc. Description and Business Overview
Table 152. West Pharmaceutical Services, Inc. Self-administered Parenteral Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. West Pharmaceutical Services, Inc. Self-administered Parenteral Product
Table 154. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Self-administered Parenteral Distributors List
Table 158. Self-administered Parenteral Customers List
Table 159. Self-administered Parenteral Market Trends
Table 160. Self-administered Parenteral Market Drivers
Table 161. Self-administered Parenteral Market Challenges
Table 162. Self-administered Parenteral Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report


List of Figures
Figure 1. Product Picture of Self-administered Parenteral
Figure 2. Global Self-administered Parenteral Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Self-administered Parenteral Market Share by Type: 2024 & 2031
Figure 4. Pre-filled Syringes Product Picture
Figure 5. Autoinjectors Product Picture
Figure 6. Pen Injectors Product Picture
Figure 7. Others Product Picture
Figure 8. Global Self-administered Parenteral Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Self-administered Parenteral Market Share by Application: 2024 & 2031
Figure 10. Pharmacy
Figure 11. Online Sales
Figure 12. Other
Figure 13. Global Self-administered Parenteral Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Self-administered Parenteral Market Size (2020-2031) & (US$ Million)
Figure 15. Global Self-administered Parenteral Sales (2020-2031) & (K Units)
Figure 16. Global Self-administered Parenteral Average Price (US$/Unit) & (2020-2031)
Figure 17. Self-administered Parenteral Report Years Considered
Figure 18. Self-administered Parenteral Sales Share by Manufacturers in 2024
Figure 19. Global Self-administered Parenteral Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Self-administered Parenteral Players: Market Share by Revenue in Self-administered Parenteral in 2024
Figure 21. Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Self-administered Parenteral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Self-administered Parenteral Sales Market Share by Country (2020-2031)
Figure 24. North America Self-administered Parenteral Revenue Market Share by Country (2020-2031)
Figure 25. United States Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Self-administered Parenteral Sales Market Share by Country (2020-2031)
Figure 28. Europe Self-administered Parenteral Revenue Market Share by Country (2020-2031)
Figure 29. Germany Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Self-administered Parenteral Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Self-administered Parenteral Revenue Market Share by Region (2020-2031)
Figure 36. China Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Self-administered Parenteral Sales Market Share by Country (2020-2031)
Figure 44. Latin America Self-administered Parenteral Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Self-administered Parenteral Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Self-administered Parenteral Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Self-administered Parenteral Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Self-administered Parenteral by Type (2020-2031)
Figure 54. Global Revenue Market Share of Self-administered Parenteral by Type (2020-2031)
Figure 55. Global Self-administered Parenteral Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Self-administered Parenteral by Application (2020-2031)
Figure 57. Global Revenue Market Share of Self-administered Parenteral by Application (2020-2031)
Figure 58. Global Self-administered Parenteral Price (US$/Unit) by Application (2020-2031)
Figure 59. Self-administered Parenteral Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies